Evidence map›Paper›PMID 42145345›Full record

ArticleBioinformation2026

Blood - brain barrier breakdown and neurovascular unit failure in the progression of Alzheimer's disease.

Suvarna Prasad, Sangeeta Gupta, Asha Premlata Omega Oraon, Ana Paula Molina Recalde, Jessica Julieta Cañarte Moreira, Génesis Nathalie Moyano Salazar, Paolo David Torres Cañarte, Camila Inés Racines Navas

Abstract read
In one paragraph

Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Suvarna PrasadDepartment of Biochemistry, AIIMS, Deoghar, Jharkhand, India.
Sangeeta GuptaDepartment of Physiology, AIIMS, Gorakhpur, Gorakhpur, Uttar Pradesh, India.
Asha Premlata Omega OraonDepartment of Biochemistry, AIIMS, Deoghar, Jharkhand, India.
Ana Paula Molina RecaldeDepartment of Medicine, Universidad San Francisco de Quito, Ecuador.
Jessica Julieta Cañarte MoreiraDepartment of Medicine, Centro Oncológico del Norte, Antofagasta, Chile.
Génesis Nathalie Moyano SalazarDepartment of Medicine, Universidad San Francisco de Quito, Ecuador.
Paolo David Torres CañarteDepartment of Medicine, Universidad San Francisco de Quito, Ecuador.
Camila Inés Racines NavasDepartment of Medicine, Universidad San Francisco de Quito, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder traditionally defined by amyloid-β deposition and tau pathology. Recent research highlights the role of blood-brain barrier (BBB) breakdown and neurovascular unit (NVU) dysfunction in disease initiation and progression. These factors contribute to neuroinflammation, cerebral hypoperfusion and impaired waste clearance. Despite this, the relationship between BBB integrity, NVU function and cognitive decline in AD remains inadequately understood. Data shows that blood-brain barrier disruption and neurovascular unit dysfunction are critical predictors of cognitive decline in Alzheimer's disease.

Indexed as

Alzheimer's disease (AD)Blood-brain barrier (BBB)cerebral perfusioncognitive impairmentneurovascular unit (NVU)

Identifiers

PMID42145345
PMCPMC13177118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.